Owlet Inc. is a leading innovator in infant health technology, focused on enhancing the safety and well-being of newborns through state-of-the-art monitoring solutions. The company's flagship product, the Owlet Smart Sock, employs advanced pulse oximetry to deliver real-time data on infants' heart rates and oxygen levels directly to parents’ mobile devices, empowering them with critical health insights. As the demand for pediatric health monitoring grows, Owlet is strategically positioned to broaden its product portfolio and solidify its standing in the dynamic infant health market. By emphasizing actionable data and improving pediatric care, Owlet is establishing a robust foothold at the intersection of healthcare and technology, appealing to institutional investors keen on innovative health solutions.
| Revenue (TTM) | $105.71M |
| Gross Profit (TTM) | $53.53M |
| EBITDA | $-8.06M |
| Operating Margin | -18.40% |
| Return on Equity | -802.00% |
| Return on Assets | -7.64% |
| Revenue/Share (TTM) | $5.84 |
| Book Value | $0.71 |
| Price-to-Book | 6.10 |
| Price-to-Sales (TTM) | 1.35 |
| EV/Revenue | 1.255 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 29.60% |
| Shares Outstanding | $28.16M |
| Float | $15.73M |
| % Insiders | 5.10% |
| % Institutions | 71.31% |